Studi Penggunaan Antihipertensi Golongan Angiotensin Reseptor Blocker (ARB) pada Pasien Chronic Kidney Disease (Penelitian dilakukan di RS Universitas Muhammadiyah Malang)
Sari
Hypertension and chronic kidney disease (CKD) are interrelated pathophysiological conditions, where sustained hypertension can lead the deterioration of renal function, and progressive deterioration of renal function can conversely result in poorer blood pressure (BP) control. Antihypertensives are given to CKD patients with the goal of lowering their blood pressure to < 140 mmHg and preventing harm to other organs. Angiotensin Receptor Blockers (ARB) are one of the first line of therapy used to reduce blood pressure in CKD patients. The research purpose was to determine the pattern of ARB regarding the type, dosage form, combination, and route of the group given to CKD patients at UMM’s General Hospital. Research was conducted in observational research with a descriptive nature and retrospective data collection on the health medical record of CKD with period January – Desember 2022. Results of the research showed that patients who met the inclusion criteria amounted to 25 patients using ARB antihypertensive therapy, the highest number of gender 52% male and 48% female, at the age of 46-55 years. The most common single use was Candesartan (1x16mg)po (5%) 2 patients, the most common combination II was Candesartan (1x16mg)po + Furosemide (3x40mg) iv 7 patients (18%), the most common combination III was Candesartan (1x16mg)po + Amlodipine (1x10mg)v + Furosemide (3x40mg)iv, the most common combination IV was Candesartan (1x16mg)po + Amlodipine (1x10mg)po + Clonidine (3x0.15mg)po + Furosemide (3x40mg)iv. There was a switch pattern as many as 13 samples (52%). Most patients met the blood pressure target at ≤ 140 mmHg.
Kata Kunci
Teks Lengkap:
PDFReferensi
Ahadiah, N., Suhardiana, H. E., & Handayani, N. (2019). EVALUASI KESESUAIAN OBAT DAN DOSIS ANTIHIPERTENSI DI INSTALASI RAWAT JALAN RUMAH SAKIT “X” KOTA TASIKMALAYA. Media Informasi, 15(2), 129–137. https://doi.org/10.37160/bmi.v15i2.409
Angin, M. P., Ayu, G., Saputri, R., Pahmi, E., Studi, P., Fakultas, F., Kesehatan, I., Malahayati, U., Evaluasi, A. :, Penggunaan, E., Kombinasi, T., Pasien, P., Di, H., Jalan, R., Hasanuddin, R., Bengkulu, D., Pada, S., & Januari, B. (2022). EVALUASI EFEKTIVITAS PENGGUNAAN TERAPI KOMBINASI PADA PASIEN HIPERTENSI DI RAWAT JALAN RSUD HASANUDDIN DAMRAH BENGKULU SELATAN PADA BULAN JANUARI-MARET 2021. Jurnal Medika Malahayati, 6(4), 434–441. https://doi.org/10.33024/JMM.V6I4.8878
Arfah, A., Amanah Makassar, S., Hariati, A., & Agustang, A. (2021). Pengaruh Penyakit Hipertensi Terhadap Kualitas Fungsi Ginjal (Studi Literatur). Journal of Health Quality Development , 1(2), 74–78. https://doi.org/10.51577/JHQD.V1I2.187
Cherub, J. (2020). Tinjauan atas Angiotensin Receptor Blocker Generasi Baru (Vol. 47, Issue 8).
Dharwina Amir, C., Cyntia Kasih, L., Kamal, A., Program Studi Pendidikan Profesi Ners, M., Keperawatan Universitas Syiah Kuala Banda Aceh, F., & Keilmuan Keperawatan Medikal Bedah, B. (2023). ASUHAN KEPERAWATAN PADA PASIEN CHRONIC KIDNEY DISEASE (CKD) : STUDI KASUS. Jurnal Ilmiah Mahasiswa Fakultas Keperawatan, 7(3). https://jim.usk.ac.id/FKep/article/view/25124
Faisal, D. R., Lazuana, T., Ichwansyah, F., Fitria, E., Riset, P., Masyarakat, K., Gizi, D., Riset, B., Nasional, I., Penelitian, B., Pengembangan, D., & Aceh, K. (2018). FAKToR RISIKo HIPERTENSI PADA USIA PRoDUKTIF DI INDoNESIA DAN UPAYA PENANGGULANGANNYA Risk Factors of Hypertension for The Productive Age in Indonesia and Prevention Measures. https://doi.org/10.22435/hsr.v25i1.5124
Hayes, P. E., Matzke, G. R., & Talbert, R. L. (n.d.). PAST EDITORS OF PHARMACOTHERAPY Editions 2-10.
Hill, R. D., N, P., & Vaidya. (2023). Angiotensin II Receptor Blockers (ARB) - StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK537027/
Hudson, J. Q., Wazny, L. D., & Komenda, P. (2021). Pharmacotherapy Handbook Eleventh Edition. https://www.facebook.com/groups/2202763316616203
Kandou, R. D., S Karinda, T. U., C Sugeng, C. E., & Sy Moeis, E. (2019). Gambaran Komplikasi Penyakit Ginjal Kronik Non Dialisis di Poliklinik Ginjal-Hipertensi RSUP Prof. Dr. R. D. Kandou Periode Januari 2017 – Desember 2018. E-CliniC, 7(2). https://doi.org/10.35790/ECL.V7I2.26878
Ku, E., Lee, B. J., Wei, J., & Weir, M. R. (2019). Hypertension in CKD: Core Curriculum 2019. American Journal of Kidney Diseases, 74(1), 120–131. https://doi.org/10.1053/J.AJKD.2018.12.044
Levin, A., Stevens, P., & Ahmed, S. (2023). KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE EVALUATION AND MANAGEMENT OF CHRONIC KIDNEY DISEASE PUBLIC REVIEW DRAFT.
Pratiwi, P. P. (2018). Kajian interaksi obat terhadap outcomes klinik pasien geriatri dengan penyakit hipertensi di Rumah Sakit Pelabuhan Jakarta Utara. https://repository.uinjkt.ac.id/dspace/handle/123456789/42319
Rosyanti, L., Studi Diploma Keperawatan, P., Keperawatan, J., Kemenkes Kendari, P., Hadi Program Studi Diploma Keperawatan, I., Isti Antari Program Studi Sarjana Ilmu Keperawatan, I., Tinggi Ilmu Kesehatan Madani, S., & Si, I. (2023). Faktor Penyebab Gangguan Psikologis pada Penderita Penyakit Ginjal Kronis yang menjalani Hemodialisis: Literatur Reviu Naratif. Health Information : Jurnal Penelitian, 15(2), e1102. https://doi.org/10.36990/hijp.v15i2.1102
Wijaya, I., Nur Kurniawan, R. K., Haris, H., Kesehatan Masyarakat, F., & Pancasakti Makassar, U. (2020). Hubungan Gaya Hidup dan Pola Makan terhadap Kejadian Hipertensi diwilayah Kerja Puskesmas Towata Kabupaten Takalar. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 3(1), 5–11. https://doi.org/10.56338/MPPKI.V3I1.1012
Zhao, H. J., Li, Y., Wang, D. Y., & Yuan, H. T. (2021). ARB might be superior to ACEI for treatment of hypertensive COVID-19 patients. In Journal of Cellular and Molecular Medicine (Vol. 25, Issue 23, pp. 11031–11034). John Wiley and Sons Inc. https://doi.org/10.1111/jcmm.17051
DOI: https://doi.org/10.33024/jfm.v7i2.15903
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
